BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

501 related articles for article (PubMed ID: 18698174)

  • 1. The role of innate immunity in autoimmune tissue injury.
    Allam R; Anders HJ
    Curr Opin Rheumatol; 2008 Sep; 20(5):538-44. PubMed ID: 18698174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toll-like receptors: emerging concepts in kidney disease.
    Anders HJ; Schlöndorff D
    Curr Opin Nephrol Hypertens; 2007 May; 16(3):177-83. PubMed ID: 17420659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Viral double-stranded RNA aggravates lupus nephritis through Toll-like receptor 3 on glomerular mesangial cells and antigen-presenting cells.
    Patole PS; Gröne HJ; Segerer S; Ciubar R; Belemezova E; Henger A; Kretzler M; Schlöndorff D; Anders HJ
    J Am Soc Nephrol; 2005 May; 16(5):1326-38. PubMed ID: 15772251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Viral 5'-triphosphate RNA and non-CpG DNA aggravate autoimmunity and lupus nephritis via distinct TLR-independent immune responses.
    Allam R; Pawar RD; Kulkarni OP; Hornung V; Hartmann G; Segerer S; Akira S; Endres S; Anders HJ
    Eur J Immunol; 2008 Dec; 38(12):3487-98. PubMed ID: 19009528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nucleic acid recognition receptors in autoimmunity.
    Krug A
    Handb Exp Pharmacol; 2008; (183):129-51. PubMed ID: 18071658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of innate immune responses in autoimmune disease development.
    Waldner H
    Autoimmun Rev; 2009 Mar; 8(5):400-4. PubMed ID: 19162250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Opposing effects of Toll-like receptor stimulation induce autoimmunity or tolerance.
    Ehlers M; Ravetch JV
    Trends Immunol; 2007 Feb; 28(2):74-9. PubMed ID: 17197239
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Role of TLR-dependent and independent pathways in autoimmunity].
    Kumagai Y; Akira S
    Nihon Rinsho; 2009 Mar; 67(3):487-93. PubMed ID: 19280921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular mimicry in innate immunity? The viral RNA recognition receptor TLR7 accelerates murine lupus.
    Anders HJ; Krug A; Pawar RD
    Eur J Immunol; 2008 Jul; 38(7):1795-9. PubMed ID: 18581336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toll-like receptors 7, 8, and 9: linking innate immunity to autoimmunity.
    Krieg AM; Vollmer J
    Immunol Rev; 2007 Dec; 220():251-69. PubMed ID: 17979852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Requirement of Toll-like receptor 7 for pristane-induced production of autoantibodies and development of murine lupus nephritis.
    Savarese E; Steinberg C; Pawar RD; Reindl W; Akira S; Anders HJ; Krug A
    Arthritis Rheum; 2008 Apr; 58(4):1107-15. PubMed ID: 18383384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of TLR inhibitors for the treatment of autoimmune diseases.
    Barrat FJ; Coffman RL
    Immunol Rev; 2008 Jun; 223():271-83. PubMed ID: 18613842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nucleic acid recognizing Toll-like receptors and autoimmunity.
    von Landenberg P; Bauer S
    Curr Opin Immunol; 2007 Dec; 19(6):606-10. PubMed ID: 18060756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of autoantibodies in the pathogenesis of lupus nephritis.
    Madaio MP
    Semin Nephrol; 1999 Jan; 19(1):48-56. PubMed ID: 9952280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toll-like receptors in autoimmunity.
    Fischer M; Ehlers M
    Ann N Y Acad Sci; 2008 Nov; 1143():21-34. PubMed ID: 19076342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lupus nephritis: from pathogenesis to targets for biologic treatment.
    Liu Y; Anders HJ
    Nephron Clin Pract; 2014; 128(3-4):224-31. PubMed ID: 25401461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IL-18 in autoimmunity: review.
    Boraschi D; Dinarello CA
    Eur Cytokine Netw; 2006 Dec; 17(4):224-52. PubMed ID: 17353157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of B cell responses by Toll-like receptors.
    Booth J; Wilson H; Jimbo S; Mutwiri G
    Cell Tissue Res; 2011 Jan; 343(1):131-40. PubMed ID: 20824286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic applications of nucleic acids as ligands for Toll-like receptors.
    Panter G; Kuznik A; Jerala R
    Curr Opin Mol Ther; 2009 Apr; 11(2):133-45. PubMed ID: 19330719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential tissue targeting of autoimmunity manifestations by autoantigen-associated Y RNAs.
    Greidinger EL; Zang Y; Martinez L; Jaimes K; Nassiri M; Bejarano P; Barber GN; Hoffman RW
    Arthritis Rheum; 2007 May; 56(5):1589-97. PubMed ID: 17469141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.